2021 Tech Meeting Link

Everything you need for the OAO 2021 Virtual Tech Meeting is on this page, including the link to the virtual content. The course offerings have changed (see list below). Please take a moment to visit our 2021 Virtual Exhibitors!


Content Available

April 5 – October 3, 2021


Frequently Ask Questions

Click here to see a list of frequently asked questions regarding the OAO 2021 Virtual Tech Meeting. This list will be updated as new questions are received.


Materials

Program
Handouts
Online Course Evaluation (required to receive CEC Certificate)
Course Evaluation PDFuse to take notes only, must complete online
Quizzesmust receive 80% or higher to receive CEC Certificate
Video/Quiz Checklistkeep track of videos and quiz scores
Virtual Exhibitors


Virtual Content is Now Live!

Click here to access virtual content


Accreditation

This program has been accredited by the International Joint Commission on Allied Health Personnel in Ophthalmology (IJCAHPO) for 7.5 CE Credits. Course Evaluation and Course Quizzes must be completed to receive CEC Certificate (see above).

This program is not sponsored by IJCAHPO; it is only reviewed for compliance with IJCAHPO standards and criteria and awarded continuing education credit accordingly; therefore, IJCAHPO cannot predict the effectiveness of the program or assure its quality in substance and presentation.


Courses

  • #1 The Pediatric Patient | Andrea Docherty, COMT, Orthopist
  • #2 Ocular Motility: Assessing the Eyes’ Drivers | Katie Kogachi, MD
  • #3 Neuro-Ophthalmic Complications of COVID-19 | Marc Dinkin, MD
  • #4 Coding Updates in Ophthalmology | Joy Woodke, COE, OCS, OCSR
  • #5 Prisms in Ophthalmic Testing | Duanna VanCamp, COT, OSC
  • #6 Ocular Manifestations of Systemic Autoimmune Diseases | Quan Dong Nguyen, MD, MSc
  • #7 The Cataract Patient | Alex Walters, MD
  • #8 The Diabetic Patient | Claudine Yee, MD
  • #9 The Glaucoma Patient | Ian Danford, MD
  • #10 Intravitreal Injections: An Overview | Marcus Altman, MD
  • #11 Diagnosing Cranial Nerve Palsies | Daniel Lee, MD
  • #12 Ocular Trauma | Michael Gale, MD
  • #13 Ophthalmic Imaging: FA and OCTA | Adam Hanif, MD
  • #14 How Will We Treat Wet AMD in 2023? | Diana V. Do, MD
  • BONUS VIDEO (not eligible for CEC): The SDOH of the Transgender Community | Dorian Scull, PA-C

2021 Faculty

Diana V. Do, MD
Byers Eye Institute, Stanford University School of Medicine

Marc Dinkin, MD
NY Presbyterian Hospital, Weill Cornell Ophthalmology Department

Quan Dong Nguyen, MD, MSc
Byers Eye Institute, Stanford University School of Medicine

Marcus Altman, MD
2nd Year Resident, OHSU/Casey Eye Institute

Ian Danford, MD
3rd Year Resident, OHSU/Casey Eye Institute

Claudine Yee, MD
2nd Year Resident, OHSU/Casey Eye Institute

Andrea Docherty, COMT
PeaceHealth

Michael Gale, MD
2nd Year Resident, OHSU/Casey Eye Institute

Adam Hanif, MD
1st Year Resident, OHSU/Casey Eye Institute

Katie Kogachi, MD
1st Year Resident, OHSU/Casey Eye Institute

Daniel Lee, MD
1st Year Resident, OHSU/Casey Eye Institute

Dorian Scull, PA-C
OHSU – Department of Urology

Duanna VanCamp, COT
Portland Community College

Alex Walters, MD
2nd Year Resident, OHSU/Casey Eye Institute

Joy Woodke, COE, OCS, OCSR
American Academy of Ophthalmology


Course Descriptions & Learning Objectives

#1 The Pediatric Patient | Andrea Docherty, COMT, Orthoptist
Course Description: Tips and tricks for a successful pediatrics exam.  This topic covers the rundown of how to communicate with the pediatric patient and their parent/guardian, the basic assessment, important things to look for, and of course ocular motility assessment at its finest.

Objectives:

  • Confidence in being able to examine and evaluate a pediatric patient for an eye exam.
  • Able to identify key history questions for a pediatric exam to help guide your evaluation.
  • Ensure proper order and administration of exam testing to ensure Binocularity and Visual Acuity are accurately assessed.

#2 Ocular Motility: Assessing the Eyes’ Drivers | Katie Kogachi, MD
Course Description: This course covers paralytic strabismus: comitant and incomitant, decompensated strabismus and secondary strabismus.  This course dives deeper into describing strabismus related syndromes and eye disease including Duane  Syndrome, Thyroid Eye Disease, Myasthenia Gravis, Multiple Sclerosis. 

Objectives:

  • Learn the basic anatomy of the extraocular muscles and the cranial nerves that control these muscles.
  • Assess for and quantify the degree of misalignment.
  • Ability to identify patterns of misalignment seen in common ocular conditions.

#3 Neuro-Ophthalmic Complications of COVID-19 | Marc Dinkin, MD
Course Description: Neuro-ophthalmic complications of COVID-19 will be described in detail. These will be organized under the rubrics of efferent and afferent function. The mechanisms by which COVID-19 may lead to neuro-ophthalmic dysfunction, including endothelial dysfunction, hypercoagulability, para-infectious inflammation and direct neurotropism will be discussed.

Objectives:

  • Understand the various types of vision loss associated with COVID-19, including cortical stroke, optic neuritis and papilledema.
  • Understand the syndromes affecting eye movements associated with COVID-19 including cranial nerve palsy, Miller Fisher syndrome, myasthenia gravis and brainstem encephalitis.
  • Understand the theoretical mechanisms by which COVID-19 may lead to neuro-ophthalmic dysfunction, including endothelial dysfunction, hypercoagulability, para-infectious inflammation and direct neurotropism.

#4 Coding Updates in Ophthalmology | Joy Woodke, COE, OCS, OCSR
Course Description: Coding updates for 2021 and what techs need to know. This talk will give attendees the latest updates to be better prepared for coding in the clinic, as it provides a comprehensive guide to coding eye exams based on physician time spent, problem, data, management and E/M & Eye coding.

Objectives:

  • Understanding the new E/M documentation guidelines effective January 1, 2021.
  • Discover resources for appropriate code selection and apply new guidelines to ophthalmic case studies.
  • Review other 2021 coding changes relevant to ophthalmology.

#5 Prism in Ophthalmic Testing | Duanna VanCamp, COT, OSC
Course Description: This course will offer tips on how to read prism in glasses using a manual lensometer and how to use prisms to measure ocular deviations.

Objectives:

  • Define a prism diopter.
  • Read prism in a manual lensometer.
  • Use prisms to measure ocular deviation.

#6 Ocular Manifestations of Systemic Autoimmune Diseases | Quan Dong Nguyen MD, MSc
Course Description: The presentation will discuss the ocular manifestations of selected autoimmune diseases including sarcoidosis, systemic lupus erythematosus, and rheumatoid arthritis, among others. 

Objectives:

  • Recognize that ocular manifestations are not uncommon in selected systemic autoimmune diseases
  • Understand that ocular manifestations may be the very initial signs of previously undiagnosed underlying systemic diseases
  • Comprehend that the management of ocular diseases in patients with underlying systemic diseases often require systemic therapy or combination of ocular and systemic therapy to provide complete control of the ocular diseases.

#7 The Cataract Patient | Alex Walters, MD
Course Description: Discusses the standard imaging techniques measuring the axial eye length with the IOL-Master and the A-scan ultrasound. It provides tips on lens selection and assisting the doctor with providing the most optimal results.  This course also covers IOL repositioning, IOL exchange and secondary IOL implants on aphakic eyes.

Objectives:

  • Learn the basics of imaging and measurement techniques.
  • Understand the pros and cons of common IOL selections.
  • Discuss IOL repositioning, exchange, and secondary IOL implants.

#8 The Diabetic Patient | Claudine Yee, MD
Course Description: This course will define Type I, Type II, gestational, secondary diabetes and pre-diabetes.  It will also identify risk factors for diabetes.  It will identify the types of insulin and its action.  A detailed discussion will provide tips for techs to focus on during the slit-lamp exam such as diabetic changes in the lids, lashes, cornea, iris, angles, crystalline lens and of course the vitreous and the retina!  Types of diabetic retinopathy are defined and treatment options are discussed. 

Objectives:

  • Understand the pathophysiology of diabetes.
  • Obtain appropriate history and workup for patients with diabetes.
  • Identify major ocular changes associated with diabetes and basic principles of management.

#9 The Glaucoma Patient | Ian Danford, MD
Course Description: This course defines types of open angle, and angle closure glaucoma.  Discussion of new glaucoma treatment options, such as new drops, i-stents, shunts, surgical, lasers and artificial intelligence.

Objectives:

  • Understand the difference between open angle glaucoma and angle closure glaucoma.
  • Understand the benefits (or lack thereof) of Rhopressa.
  • Understand the general principles behind the use of minimally invasive glaucoma surgeries (MIGS).

#10 Intravitreal Injections:  An Overview | Marcus Altman, MD
Course Description: This discussion will cover the different types of intravitreal injections that are currently available for some of the most common diagnostics conditions, such as AMD, DM and other retinal pathology.

Objectives:

  • Understand indications for use of intravitreal injections in common ophthalmic conditions.
  • List the classes of medications used for intravitreal injections and their basic mechanisms of action.
  • Discuss a general technique/procedure for administering intravitreal injections, and their potential risks/complications.

#11 Diagnosing Cranial Nerve Palsies | Daniel Lee, MD
Course Description: This course will cover basic brain and orbital anatomy as it relates to cranial nerves and how to identify common cranial nerve palsies seen within ophthalmology. It will cover tips and tricks to look for on examination as well as things to ask about during history taking.

Objectives:

  • Better understand basic brain and orbital anatomy as it relates to cranial nerves.
  • Identify important things to ask during history taking and examination findings to note during initial encounter.
  • Identify common cranial nerve palsies seen within ophthalmology.

#12 Ocular Trauma | Michael Gale, MD
Course Description: This talk will cover the basic work-ups for an ocular trauma patient, and provide examples of different types of trauma, triage and assessment and treatment.  The course will go over the classifications of eye injuries, tissue reactions to injuries, early and late complications. Types of ocular trauma will be identified such as blunt trauma, penetrating trauma, chemical injuries radiation injuries and thermal injuries.     

Objectives:

  • Able to recognize signs of ocular trauma.
  • Able to safely examine patients with ocular trauma.
  • Able to appropriately triage patients with ocular trauma.

#13 Ophthalmic Imaging: FA and OCTA | Adam Hanif, MD
Course Description: This course will provide tips and tricks for FA and OCTA imaging. A descriptive interpretation of the phases of the angiogram in fluorescein angiography will be given. Abnormal angiogram findings such as hyperfluorescence, transmission defects, leakage, pooling and hypofluorescence.  Clinical skills and quality concerns will be addressed.  The course will also identify findings that can be picked up with angiography such as: diabetic retinopathy, dry and wet AMD, vascular occlusions, macular telangiectasia and choroidal neovascular membranes. 

Objectives:

  • List the key phases of fluorescein angiography.
  • Recognize classic abnormal fluorescein angiography findings.
  • Describe FA and OCTA findings of common retinal diseases.

#14 How Will We Treat Wet AMD in 2023? | Diana V. Do, MD
Course Description: Current therapies for wet AMD involve intravitreal anti-VEGF agents. New biologics are currently in clinical trials for wet AMD and retinal vascular diseases. These new agents may provide additional benefit by enhancing the durability of VEGF blockage in order to improve long term visual outcomes. In addition, additional targets to inhibit angiogenesis and vascular permeability are being explored.

Objectives:

  • Review the current biologics in late stage development for wet AMD
  • Discuss the efficacy and safety of these new biologics.
  • Discuss the dosing regimens for new biologics in evidence.